05-Nov-2026 13:06:13
SHILPAMEDGeneral news
SHILPA MEDICARE Q2 FY27 ; CONS NET PROFIT UP 79.67% AT ₹79.18 CR (YOY), DOWN 21.51% (QOQ)
REVENUE UP 42.96% AT ₹529.12 CR (YOY), UP 13.60% (QOQ) EBITDA UP 31.25% AT ₹142.39 CR (YOY), UP 4.50% (QOQ) MARGINS AT 26.91% VS 29.31% (YOY), 29.25% (QOQ)
SHILPA MEDICARE LTD